{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:05:25Z","timestamp":1790067925595,"version":"4.0.1"},"reference-count":27,"publisher":"Rockefeller University Press","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":285,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"Intramural Research Program of the National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1092074"],"award-info":[{"award-number":["OPP1092074"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1124068"],"award-info":[{"award-number":["OPP1124068"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HIVRAD P01 AI100148"],"award-info":[{"award-number":["HIVRAD P01 AI100148"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health Center for HIV\/AIDS Vaccine Immunology and Immunogen Discovery","doi-asserted-by":"publisher","award":["1UM1 AI100663-01"],"award-info":[{"award-number":["1UM1 AI100663-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01 AI138212"],"award-info":[{"award-number":["P01 AI138212"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012007","name":"Rockefeller University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012007","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013961","name":"Robertson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013961","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1,4]]},"abstract":"<jats:p>We report that combination bNAb immunotherapy initiated on day 3 post-infection (PI) maintained durable CD8+ T cell\u2013mediated suppression of SHIVAD8 viremia and preinoculation levels of CD4+ T cells in 9 of 13 treated monkeys during nearly 6 yr of observation, as assessed by successive CD8+ T cell\u2013depletion experiments. In an extension of that study, two treatment interventions (bNAbs alone or cART plus bNAbs) beginning on week 2 PI were conducted and conferred controller status to 7 of 12 monkeys that was also dependent on control mediated by CD8+ cells. However, the median time to suppression of plasma viremia following intervention on week 2 was markedly delayed (85 wk) compared with combination bNAb immunotherapy initiated on day 3 (39 wk). In both cases, the principal correlate of virus control was the induction of CD8+ T cellular immunity.<\/jats:p>","DOI":"10.1084\/jem.20201214","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T13:24:16Z","timestamp":1600867456000},"update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":51,"title":["Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia"],"prefix":"10.1084","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-2368","authenticated-orcid":true,"given":"Yoshiaki","family":"Nishimura","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8184-7849","authenticated-orcid":true,"given":"Olivia K.","family":"Donau","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-8770","authenticated-orcid":true,"given":"Joana","family":"Dias","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-555X","authenticated-orcid":true,"given":"Sara","family":"Ferrando-Martinez","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7501-4541","authenticated-orcid":true,"given":"Eric","family":"Jesteadt","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3605-5196","authenticated-orcid":true,"given":"Reza","family":"Sadjadpour","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2390-8727","authenticated-orcid":true,"given":"Rajeev","family":"Gautam","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3357-0328","authenticated-orcid":true,"given":"Alicia","family":"Buckler-White","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-8811","authenticated-orcid":true,"given":"Romas","family":"Geleziunas","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Inc., Foster City, CA 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3090-7282","authenticated-orcid":true,"given":"Richard A.","family":"Koup","sequence":"additional","affiliation":[{"name":"Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-8564","authenticated-orcid":true,"given":"Michel C.","family":"Nussenzweig","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology, Rockefeller University, New York, NY 4"},{"name":"Howard Hughes Medical Institute, Rockefeller University, New York, NY 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-9905","authenticated-orcid":true,"given":"Malcolm A.","family":"Martin","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"key":"2023072122163305300_bib1","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"2023072122163305300_bib2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41586-018-0600-6","article-title":"Antibody and TLR7 agonist delay viral rebound in SHIV-infected monkeys","volume":"563","author":"Borducchi","year":"2018","journal-title":"Nature"},{"key":"2023072122163305300_bib3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"2023072122163305300_bib4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nm.4268","article-title":"Antibody 10-1074 suppresses viremia in HIV-1-infected individuals","volume":"23","author":"Caskey","year":"2017","journal-title":"Nat. Med"},{"key":"2023072122163305300_bib5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","article-title":"Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy","volume":"27","author":"Deeks","year":"2007","journal-title":"Immunity"},{"key":"2023072122163305300_bib6","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.1128\/JVI.74.15.6935-6945.2000","article-title":"Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian\/human immunodeficiency virus","volume":"74","author":"Endo","year":"2000","journal-title":"J. Virol"},{"key":"2023072122163305300_bib7","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1172\/JCI96207","article-title":"Accumulation of follicular CD8+ T cells in pathogenic SIV infection","volume":"128","author":"Ferrando-Martinez","year":"2018","journal-title":"J. Clin. Invest"},{"key":"2023072122163305300_bib8","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature17677","article-title":"A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges","volume":"533","author":"Gautam","year":"2016","journal-title":"Nature"},{"key":"2023072122163305300_bib9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41591-018-0001-2","article-title":"A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection","volume":"24","author":"Gautam","year":"2018","journal-title":"Nat. Med"},{"key":"2023072122163305300_bib10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF02101694","article-title":"Dating of the human-ape splitting by a molecular clock of mitochondrial DNA","volume":"22","author":"Hasegawa","year":"1985","journal-title":"J. Mol. Evol"},{"key":"2023072122163305300_bib11","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nm.4063","article-title":"Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques","volume":"22","author":"Hessell","year":"2016","journal-title":"Nat. Med"},{"key":"2023072122163305300_bib12","doi-asserted-by":"publisher","first-page":"13813","DOI":"10.1073\/pnas.212511599","article-title":"Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus\/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic","volume":"99","author":"Imamichi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072122163305300_bib13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/cei.12692","article-title":"Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults","volume":"182","author":"Ledgerwood","year":"2015","journal-title":"Clin. Exp. Immunol"},{"key":"2023072122163305300_bib14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"Lu","year":"2016","journal-title":"Science"},{"key":"2023072122163305300_bib15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad5752","article-title":"Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection","volume":"7","author":"Lynch","year":"2015","journal-title":"Sci. Transl. Med"},{"key":"2023072122163305300_bib16","doi-asserted-by":"publisher","first-page":"18921","DOI":"10.1073\/pnas.1214785109","article-title":"Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo","volume":"109","author":"Moldt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072122163305300_bib17","doi-asserted-by":"publisher","first-page":"E3268","DOI":"10.1073\/pnas.1217207109","article-title":"Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies","volume":"109","author":"Mouquet","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072122163305300_bib18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat. Med"},{"key":"2023072122163305300_bib19","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1128\/JVI.02279-09","article-title":"Generation of the pathogenic R5-tropic simian\/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques","volume":"84","author":"Nishimura","year":"2010","journal-title":"J. Virol"},{"key":"2023072122163305300_bib20","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature21435","article-title":"Early antibody therapy can induce long-lasting immunity to SHIV","volume":"543","author":"Nishimura","year":"2017","journal-title":"Nature"},{"key":"2023072122163305300_bib21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/526786","article-title":"Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy","volume":"197","author":"Pereyra","year":"2008","journal-title":"J. Infect. Dis"},{"key":"2023072122163305300_bib22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag2285","article-title":"Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies","volume":"9","author":"Petrovas","year":"2017","journal-title":"Sci. Transl. Med"},{"key":"2023072122163305300_bib23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"2023072122163305300_bib24","doi-asserted-by":"publisher","first-page":"19769","DOI":"10.1073\/pnas.1217443109","article-title":"Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains","volume":"109","author":"Shingai","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023072122163305300_bib25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nature12746","article-title":"Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia","volume":"503","author":"Shingai","year":"2013","journal-title":"Nature"},{"key":"2023072122163305300_bib26","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1084\/jem.20132494","article-title":"Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques","volume":"211","author":"Shingai","year":"2014","journal-title":"J. Exp. Med"},{"key":"2023072122163305300_bib27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/molbev\/msz312","article-title":"Molecular Evolutionary Genetics Analysis (MEGA) for macOS","volume":"37","author":"Stecher","year":"2020","journal-title":"Mol. Biol. Evol"}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20201214\/1456087\/jem_20201214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/doi\/10.1084\/jem.20201214\/1456087\/jem_20201214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T22:17:19Z","timestamp":1689977839000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/218\/1\/e20201214\/152113\/Immunotherapy-during-the-acute-SHIV-infection-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,4]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20201214","relation":{},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"article-number":"e20201214"}}